|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007778,
umls-concept:C0021756,
umls-concept:C0152463,
umls-concept:C0278348,
umls-concept:C0282460,
umls-concept:C0443252,
umls-concept:C0595451,
umls-concept:C0812413,
umls-concept:C1306673,
umls-concept:C1522449,
umls-concept:C1883256,
umls-concept:C2678502
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-2-19
|
|
pubmed:abstractText |
From therapeutic nihilism to extremely aggressive management, there is a wide range of possibilities in the treatment of malignant pleural mesothelioma (MPM). Unfortunately, there is little evidence as regards the best treatment to offer to the MPM patients. In 1999, we started a phase II study based on the multimodality treatment of stage II-III MPM, the results of which have been analysed and reported.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1010-7940
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
529-33; discussion 533-4
|
|
pubmed:meshHeading |
pubmed-meshheading:17188885-Adult,
pubmed-meshheading:17188885-Aged,
pubmed-meshheading:17188885-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17188885-Chemotherapy, Adjuvant,
pubmed-meshheading:17188885-Combined Modality Therapy,
pubmed-meshheading:17188885-Drug Administration Schedule,
pubmed-meshheading:17188885-Female,
pubmed-meshheading:17188885-Humans,
pubmed-meshheading:17188885-Interleukin-2,
pubmed-meshheading:17188885-Male,
pubmed-meshheading:17188885-Mesothelioma,
pubmed-meshheading:17188885-Middle Aged,
pubmed-meshheading:17188885-Neoplasm Staging,
pubmed-meshheading:17188885-Pleura,
pubmed-meshheading:17188885-Pleural Neoplasms,
pubmed-meshheading:17188885-Radiotherapy, Adjuvant,
pubmed-meshheading:17188885-Survival Analysis,
pubmed-meshheading:17188885-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
|
|
pubmed:affiliation |
Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy. m.lucchi@med.unipi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
